Loading...
Keywords
Last Name
Institution

Connection

Search Results to

This is a "connection" page, showing the details of why an item matched the keywords from your search.


One or more keywords matched the following properties of Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.

PropertyValue
has major subject area list Anti-Inflammatory Agents, Non-Steroidal; Cytochrome P-450 CYP2C9; Drug-Related Side Effects and Adverse Reactions; Pharmacogenetics; Pharmacogenomic Testing; Pharmacogenomic Variants
information resource reference Theken KN, Lee CR, Gong L, Caudle KE, Formea CM, Gaedigk A, Klein TE, Ag?ndez JAG, Grosser T. Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs. Clin Pharmacol Ther. 2020 08; 108(2):191-200.
label Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs.

Search Criteria
  • CYP2C9